(EFAS) Global X MSCI SuperDividend - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US37954Y6995 • Foreign Large Value
EFAS: Dividend, Stocks, Equities, Securities, Companies, ETFs
The Global X MSCI SuperDividend® EAFE ETF (NASDAQ:EFAS) is an exchange-traded fund (ETF) designed to provide exposure to high-dividend-yielding equities in developed markets outside North America. The fund invests at least 80% of its total assets in the securities of the underlying MSCI EAFE Top 50 Dividend Index, which tracks the performance of 50 equally-weighted companies with the highest dividend yields in Europe, Australasia, and the Far East.
As part of its investment strategy, the ETF focuses on dividend-paying stocks, appealing to yield-focused investors. The funds equal-weighting approach ensures that each company in the portfolio has a similar influence on performance, reducing concentration risk. The ETF is listed on the NASDAQ exchange under the ticker symbol EFAS and falls under the Foreign Large Value ETF category.
From a technical perspective, EFAS has shown a recent price of $15.96, with a 20-day average volume of 2130 shares. The funds short-term trend is indicated by its SMA 20 of $14.94, while its SMA 50 and SMA 200 stand at $14.39 and $14.30, respectively. The Average True Range (ATR) of 0.14 reflects relatively low volatility in recent trading activity.
In terms of fundamental analysis, the ETF has assets under management (AUM) of $8.98 million, which is relatively small compared to other ETFs in its category. This smaller size may result in lower trading liquidity and higher sensitivity to market movements.
Looking ahead, the 3-month forecast for EFAS is influenced by both technical and fundamental factors. Based on the current SMA trends, the funds price may experience sideways movement, potentially stabilizing near its SMA 50 and SMA 200 levels. The low ATR suggests that volatility is likely to remain muted, with the price range possibly narrowing between $14.30 and $16.50. From a fundamental perspective, the EAFE regions economic outlook and dividend yield trends will play a critical role in shaping the funds performance during this period.
Additional Sources for EFAS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EFAS ETF Overview
Market Cap in USD | 10m |
Category | Foreign Large Value |
TER | 0.56% |
IPO / Inception | 2016-11-10 |
EFAS ETF Ratings
Growth Rating | 68.1 |
Fundamental | - |
Dividend Rating | 81.5 |
Rel. Strength | 12.4 |
Analysts | - |
Fair Price Momentum | 16.74 USD |
Fair Price DCF | - |
EFAS Dividends
Dividend Yield 12m | 6.33% |
Yield on Cost 5y | 11.93% |
Annual Growth 5y | 8.14% |
Payout Consistency | 82.8% |
EFAS Growth Ratios
Growth Correlation 3m | 75.6% |
Growth Correlation 12m | 56.8% |
Growth Correlation 5y | 72.9% |
CAGR 5y | 14.71% |
CAGR/Max DD 5y | 0.51 |
Sharpe Ratio 12m | 1.64 |
Alpha | 13.31 |
Beta | 1.000 |
Volatility | 37.76% |
Current Volume | 14k |
Average Volume 20d | 12.7k |
As of April 18, 2025, the stock is trading at USD 15.84 with a total of 14,044 shares traded.
Over the past week, the price has changed by +6.45%, over one month by -1.56%, over three months by +14.82% and over the past year by +19.91%.
Yes. Based on ValueRay Analyses, Global X MSCI SuperDividend (NASDAQ:EFAS) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.07 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EFAS as of April 2025 is 16.74. This means that EFAS is currently overvalued and has a potential downside of 5.68%.
Global X MSCI SuperDividend has no consensus analysts rating.
According to ValueRays Forecast Model, EFAS Global X MSCI SuperDividend will be worth about 18.6 in April 2026. The stock is currently trading at 15.84. This means that the stock has a potential upside of +17.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 18.6 | 17.3% |